Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Xuechi Lin"'
Publikováno v:
International Journal of Molecular Medicine. 40:235-242
Purvalanol A is a highly selective inhibitor of Cdc2 [also known as cyclin-dependent kinase 1 (CDK1)]. Taxol is an anti-tumor chemotherapeutic drug which is widely used clinically. In this study, the CDK1 inhibitor, purvalanol A was applied to explor
Publikováno v:
Oncology reports. 41(3)
Our previous studies demonstrated that high expression of oncoprotein 18 (Op18)/stathmin promotes malignant transformation of non‑small cell lung cancer NCI‑H1299 cells. Investigation of the cellular settings determined that NCI‑H1299 cells wer
Publikováno v:
Oncology reports. 41(1)
Our previous studies have identified that silencing oncoprotein 18 (Op18)/stathmin via RNA interference (RNAi) inhibited autocrine interleukin‑10 (IL‑10) and enhanced the sensitivity to Taxol in NCI‑H1299 non‑small cell lung cancer cells. In
Publikováno v:
Cell biology and toxicology. 34(1)
Stathmin (STMN) plays a vital role in maintaining the malignant behavior of cancer through directly regulating microtubule dynamics equilibrium. Taxol, an effective chemotherapeutics mainly acting to promote microtubule polymerization, has been comme
Publikováno v:
Oncology reports. 37(4)
Taxol (paclitaxel) and vinblastine (VBL) are both efficacious chemotherapeutic agents that target the microtubules of tumor cells, but each functions in a mutual antagonistic manner. Op18/stathmin is a small molecular phosphoprotein which promotes de
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 31(2)
Taxol is a cytotoxic antiepithelioma chemotherapy drug widely used clinically, which results in appearing a broad range of taxol-resistant tumors. Oncoprotein 18 (Op18)/stathmin is a genetically highly conserved small-molecule cytosolic phosphoprotei
Op18/stathmin is involved in the resistance of taxol among different epithelial carcinoma cell lines
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 29(9)
Taxol is an effective chemotherapeutic agent against epithelial-derived carcinomas, and resistance of carcinoma cells to taxol has developed with the wide prescription of the drug. In this study, five different epithelial carcinoma cell lines were ra
Autor:
Min Tang, Lili Li, Zijian Li, Xuechi Lin, Juan Xu, Xiaoqian Ma, Ya Cao, Sufang Liu, Lili Guo, Yongguang Tao
Publikováno v:
Cancer Sci
The MAPKs are activated by a variety of cellular stimuli to participate in a series of signaling cascades and mediate diverse intracellular responses. One potential target of the MAPKs is Op18/stathmin, a molecule that acts as an integrator of divers
Autor:
Xiaoqian Ma, Lili Li, Yongguang Tao, Zijian Li, Lili Guo, Xuechi Lin, Xiangjian Luo, Sufang Liu, Ya Cao
Publikováno v:
International journal of cancer. 124(5)
Oncoprotein 18/stathmin (Op18/stathmin) plays a crucial role in maintaining cell biological characteristics by regulating microtubule dynamics, especially entry into mitosis; phosphorylated Op18/stathmin promotes microtubule polymerization to form th
Autor:
Yanfei Gong, Xuechi Lin, Liting Cai, Zuping Zhang, Wei Liu, Shun-ke Zhang, Qingren Zeng, Benwen Li, Tiebing Zeng
Publikováno v:
The Journal of parasitology. 94(2)
We previously reported that immunization with intact live cells from schistosomula of Schistosoma japonicum (S.j) partially protected the Kunming strain of mice from challenge infection. In the present work, 2 immune protective experiments were desig